You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenoma, Islet Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Development of New Personalised 3D Preclinical Models of

Recruiting
  • Pancreatic Neuroendocrine Tumor
    • Milan, MI, Italy
      IRCCS San Raffele Institute
    Nov 2, 2023

    Multi-dimensional Fragmentomic Assay for Early Detection of

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Fragmentomic profiles of plasma cfDNA
    • (no location specified)
    Apr 27, 2023

    VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

    Recruiting
    • VHL Pancreatic Neuroendocrine Tumors
    • +2 more
    • 68-Gallium DOTATATE
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

    Recruiting
    • Pancreatic Neuroendocrine Tumor
    • peptide receptor radionuclide therapy with Y-90-DOTATOC
    • Milano, Italy
    • +1 more
    Sep 30, 2022

    Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

    Recruiting
    • Nonfunctional Pancreatic Neuroendocrine Tumor
    • +2 more
    • EUS-guided ethanol ablation
    • EUS-guided lauromacrogol ablation
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 30, 2022

    Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Pancreas Cancer
    • cytoreductive surgery
    • +2 more
    • Chicago, Illinois
      The University of Chicago
    Nov 8, 2022

    Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

    Recruiting
    • Multiple Endocrine Neoplasia Type 1
    • Pancreatic Neuroendocrine Tumor
    • EUS-guided fine-needle injection
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 24, 2022

    Genetic Predisposition Testing Program for Pancreatic

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Hereditary Cancer Panel
    • Los Angeles, California
    • +2 more
    Feb 17, 2023

    Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

    Not yet recruiting
    • Digestive System Neuroendocrine Tumor G1
    • +5 more
    • Tumor Debulking
    • +5 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Aug 23, 2023

    Pancreatic Neuroendocrine Tumor Trial in Shanghai (Nimotuzumab)

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Apr 4, 2022

    Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • Unresectable Pancreatic Neuroendocrine Carcinoma
    • Lutetium Lu 177 Dotatate
    • +4 more
    • (no location specified)
    Feb 10, 2022

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Collecting Medical Information and Tissue Samples From

    Recruiting
    • Islet Cell Tumor
    • +2 more
    • medical chart review
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic Cancer Center
    Sep 28, 2021

    Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)

    Active, not recruiting
    • Pancreatic Neuroendocrine Tumors
    • Beijing, Beijing, China
    • +3 more
    Sep 27, 2021

    Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • +4 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jan 14, 2023

    Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

    Terminated
    Has Results
    • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
    • Bruxelles, Belgium
    • +23 more
    Dec 21, 2022

    Gastro-entero-pancreatic Neuroendocrine Tumors Trial in Meldola (Capecitabine, Lu-PRRT, SS-LAR)

    Active, not recruiting
    • Gastro-entero-pancreatic Neuroendocrine Tumors
    • Meldola, FC, Italy
      Irst Irccs
    Feb 25, 2021

    Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • +4 more
    • Ames, Iowa
    • +5 more
    Dec 3, 2021

    Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors Trial in Meldola, Milan (28 GBq 177Lu-DOTATATE, 22 GBq

    Active, not recruiting
    • Neuroendocrine Tumors
    • Gastro Entero Pancreatic Neuroendocrine Tumors
    • 28 GBq 177Lu-DOTATATE
    • 22 GBq 177Lu-DOTATATE
    • Meldola, FC, Italy
    • +1 more
    Feb 25, 2021

    Sunitinib In Chinese Progressive Advanced Or Metastatic

    Active, not recruiting
    • Pancreatic Neuroendocrine Tumors
    • Hefei, Anhui, China
    • +15 more
    Oct 19, 2021

    Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor

    Completed
    Has Results
    • Advanced Digestive System Neuroendocrine Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 8, 2020

    Nephrologic Prognosis 10 Years After Diabetes Cell Therapy

    Completed
    • Islet Transplantation
    • islet transplanted
    • non islet transplanted
    • Lille, France
      Lille University Hospital
    Apr 28, 2022

    Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

    Not yet recruiting
    • Islet Transplantation
    • Infusion of recipient T regulatory cell
    • Infusion of concomitant Donor Derived Vertebral Bone Marrow
    • Palo Alto, California
      Stanford University
    Jul 25, 2023

    Pancreatic Neuroendocrine Tumor Trial in Boston (RAD001, Temozolomide)

    Completed
    Has Results
    • Pancreatic Neuroendocrine Tumor
    • Boston, Massachusetts
    • +2 more
    Jun 26, 2020